- Home
- AMLX vs BRAI Comparison
AMLX vs BRAI Comparison
Compare AMLX & BRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$14.05
Company Overview
Basic Information| Metric | AMLX | BRAI |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMLX | BRAI |
|---|---|---|
| Price | $14.05 | $24.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $19.56 | N/A |
| AVG Volume (30 Days) | ★ 774.9K | 115.7K |
| Earning Date | 06-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $3.11 | $12.56 |
| 52 Week High | $17.49 | $32.32 |
Technical Indicators
Market Signals| Indicator | AMLX | BRAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 51.63 |
| Support Level | $13.28 | $13.10 |
| Resistance Level | $15.27 | $25.00 |
| Average True Range (ATR) | 0.92 | 7.70 |
| MACD | -0.03 | 0.63 |
| Stochastic Oscillator | 14.61 | 58.60 |
Price Performance
Historical Comparison AMLX
BRAI
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.